First and only BTK inhibitor to demonstrate favourable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
This fresh infusion of capital will enable ImmunoACT to fast track the additional supply of the lead candidate HCAR-19
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Testing supporting allergy diagnosis now accessible to more people in more communities
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
Subscribe To Our Newsletter & Stay Updated
